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then 5 g cHO on training days) while participating in a 
high intensity resistance training program [3 sets × 10 
repetitions at 75 % of 1 repetition maximum (1rM)], 
3 days weeks−1 for 12 weeks. Following the initial 7-day 
“loading” phase, participants were instructed to ingest their 
supplement within 60 min post-exercise. Body composi-
tion and muscle strength measurements, blood collection 
and vastus lateralis muscle biopsy were completed at 0, 4, 
8 and 12 weeks of the supplement and resistance training 
program.
Results A significant time effect was observed for 1rM 
bench press (p = 0.016), leg press (p = 0.012), body mass 
(p = 0.03), fat-free mass (p = 0.005) and total myofibrillar 
protein (p = 0.005). A trend for larger muscle fiber cross-
sectional area in the type II fibers compared to type I fib-
ers was observed following the 12-week resistance train-
ing (p = 0.08). no supplement interaction effects were 
observed.
Conclusion Post-exercise ingestion of creatine monohy-
drate does not provide greater enhancement of body com-
position and muscle strength compared to resistance train-
ing alone in middle to older males.
Keywords Supplementation · Aging · Muscle · 
Hypertrophy · creatine · Supplementation
Abbreviations
1rM  1 repetition maximum
AcSM  American college of Sports Medicine
cHO  carbohydrate
crM  creatine monohydrate
cSA  cross sectional area
DEXA  Dual energy X-ray absorptiometry
ElISA  Enzyme-linked immunoabsorbent assay
gH  growth hormone
Abstract 
Purpose the present study evaluated the effects of cre-
atine monohydrate (crM) consumption post-exercise on 
body composition and muscle strength in middle to older 
males following a 12-week resistance training program.
Methods In a double-blind, randomized trial, 20 males 
aged between 55 and 70 years were randomly assigned to 
consume either crM-carbohydrate (cHO) [20 g days−1 
crM + 5 g days−1 cHO × 7 days, then 0.1 g kg−1 
crM + 5 g cHO on training days (average dosage of 
~8.8 g)] or placebo cHO (20 g days−1 cHO × 7 days, 
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Icc  Intraclass correlation coefficient
IgF-1  Insulin-like growth factor 1
MAnOVA  Multivariate analysis of variance
rnA  ribonucleic acid
SD  Standard deviation
Introduction
Aging is associated with progressive loss of neuromuscular 
function that often leads to progressive disability and loss 
of independence. Sarcopenia is now a commonly used term 
to describe the loss of skeletal muscle mass and strength 
that occurs in concert with biological aging (Janssen et al. 
2002; Bales and ritchie 2002; Borst 2004). By the seventh 
and eighth decade of life, muscle strength can be reduced, 
on average, by approximately 20–40 % for both men and 
women (Doherty 2003). Although age-associated decreases 
in strength per unit of muscle mass (i.e. muscle quality) 
may play a role, a large proportion of strength loss can be 
accounted for by decreased muscle mass (Doherty 2003). 
Multiple factors have been implicated in the development 
of sarcopenia and the associated impact on function. loss 
of skeletal muscle fibers secondary to decreased numbers 
of motor neurons appears to be a major contributing influ-
ence, but other factors, including decreased physical activ-
ity, altered hormonal status, decreased total caloric and pro-
tein intake, inflammatory mediators, and factors leading to 
altered protein synthesis must also be considered (Buford 
et al. 2010).
In the past decade, strength training has been investi-
gated extensively as a means of attenuating sarcopenia 
(Hunter et al. 2004; candow and chilibeck 2007). Indeed, 
high intensity resistance training is known to increase 
myofibrillar protein synthesis as well as muscle hypertro-
phy (candow and chilibeck 2007). However, literature 
suggests that despite training, muscle loss may still occur in 
older adults, indicating factors including nutrition may also 
play an important role in combating sarcopenia (campbell 
and leidy 2007).
One potentially efficacious method of leveraging nutri-
tion to enhance the efficacy of resistance training is sup-
plementation with creatine monohydrate (crM). In ath-
letic populations, crM has been extensively studied over 
the past 20 years, with its effects on high intensity, short-
term exercise well-documented (rawson and Volek 2003; 
Williams and Branch 1998; chrusch et al. 2001). to date, 
available evidence regarding the ergogenic effect of crM 
supplementation in older adults is equivocal as some stud-
ies have reported improvement (rawson and Wehnert 
1999; gotshalk et al. 2007; Brose and Parise 2003) or no 
change (Elliot et al. 2008; Bemben et al. 2010; Olsen et al. 
2006) in various measures of body composition and muscle 
performance. In recent years, it has been suggested that the 
timing of nutritional supplementation in close proximity of 
an exercise bout maybe more important than absolute daily 
intake of the supplements (cribb and Hayes 2006; candow 
and chilibeck 2008; Antonio and ciccone 2013). numer-
ous studies have shown the benefit of protein timing on 
adaptations to resistance exercise in both young and older 
populations (Stark et al. 2012). However, research into the 
ergogenic potential of creatine ingestion in close proxim-
ity to exercise completion is limited. In young males and 
females, creatine ingestion (0.2 g kg−1, average dosage 
of ~15.5 g) following a single limb exercise for 6 weeks 
increased lean muscle mass (males only) and elbow flexor 
muscle thickness to a greater extent than placebo ingestion 
(chilibeck et al. 2004). conversely, creatine taken before 
and after exercise training at a lower dosage (0.1 g kg−1, 
average dosage of ~5.7 g) failed to provide any further 
increases in body mass, lean muscle mass and total mus-
cle thickness when compared to placebo ingestion in older 
males (candow et al. 2008). recently, Antonio and ciccone 
(2013) showed that consuming as little as 5 g of creatine 
post-exercise may affect the adaptive response to exercise 
in young male bodybuilders. However, the purpose of this 
study was to compare pre- vs. post-exercise consumption 
of creatine and thus a true control (i.e., no supplement) was 
not included (Antonio and ciccone 2013). Subsequently, 
the effectiveness of creatine ingestion in close proximity of 
resistance exercise at a lower dosage is unclear.
While continuous crM supplementation (acute or long 
term) appears to enhance resistance training-induced mus-
cle adaptations in young and older individuals, the benefit 
of timing creatine ingestion relative to the resistance exer-
cise session is unclear. therefore, the primary purpose of 
this study was to determine the effect of post-exercise crM 
consumption on body composition and muscle strength in 
middle to older males. We hypothesized that post-exercise 
crM consumption concurrent with a resistance training 
program would result in greater training enhancement in 
upper and lower body muscle strength, lean muscle mass, 
muscle fiber cross-sectional area (cSA) when compared to 
cHO ingestion.
Materials and methods
Participants
twenty-eight apparently healthy male participants between 
the ages of 55–70 years began this study. A total of eight 
participants were unable to complete the study for the fol-
lowing reasons: time commitment (4), uncomfortable with 
muscle biopsy procedure (2), and non-study related injury 
(2). A total of 20 participants (10 per group) completed 
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all testing sessions and all 20 participants were used for 
subsequent analysis of all variables. Sample size was cal-
culated using g Power software. Based on expected lean 
muscle mass changes (chrusch et al. 2001) for the creatine 
and placebo groups of 55.85 ± 1.65 and 51.45 ± 1.35 kg, 
respectively, the calculated effect size is 2.92. With an α of 
0.05, a sample size of 8 per group yields a power of 0.92.
Participants were recreationally active (i.e. performed 
exercise 1–2 days weeks−1) but non-resistance trained (i.e. 
no regular resistance training for at least 1 year) Exclusion-
ary criteria included smoking during previous year, use of 
nutritional supplements or supplemental androgens within 
the previous 6 months, current use of statins, recent history 
of cancer (within 2 years), neurological disease or cardiac 
arrhythmia interfering with physical function, peripheral 
vascular disease, congestive heart failure, complicated dia-
betes, chronic inflammatory disease, recent stroke (within 
1 year), renal/kidney disease, and any absolute contrain-
dications to exercise according to American college of 
Sports Medicine (AcSM) guidelines.
All eligible participants were asked to provide oral and 
written informed consent based on documents approved by 
the Institutional review Board of Baylor University. All 
experimental procedures involved in the study conformed 
to the ethical consideration of the Helsinki code. Verbal 
explanation of the purpose of the research, the protocol to 
be followed, and the experimental procedures to be used 
were given to the participants.
Entry and familiarization session
Participants expressing interest in participating in this study 
were interviewed on the phone and/or via email to deter-
mine whether they appeared to qualify to participate in 
this study. Participants believed to meet eligibility criteria 
were then invited to attend an entry/familiarization session. 
Participants were asked to bring signed physician approval 
of participation to the familiarization session. During this 
session, the potential participants signed informed consent 
statements and completed personal and medical history 
forms. Participants meeting entry criteria were familiarized 
to the study protocol, and the tests to be performed, via a 
verbal and written explanation outlining the study design. 
Participants were instructed to refrain from exercise for 
48 h and fast for 8 h prior to testing.
Experimental design
Upon reporting to the lab for the exercise testing session, 
body mass, heart rate and blood pressure were determined 
prior to analyzing body composition using dual X-ray 
absorptiometry (DEXA) (Hologic, Waltham, MA). Fol-
lowing the DEXA scan, venous blood and skeletal muscle 
biopsy samples were obtained by standard/sterile proce-
dures. Participants then performed upper body and lower 
body 1 repetition maximum (1rM) strength measure-
ments. Participants were then matched on lower body 1rM 
strength, age and fat-free mass and randomly assigned to 
consume either crM-cHO or cHO placebo while partici-
pating in a high intensity resistance training program (3 
sets × 10 repetitions at 75 % of 1rM), 3 days weeks−1 for 
12 weeks. At 4 (t2), 8 (t3) and 12 (t4) weeks, participants 
returned to the lab to perform the same battery of tests as 
performed at baseline (t1) 48 h after the last workout. A 
total of four blood and muscle biopsy samples were taken 
during the study.
Muscle strength assessment
At 0, 4, 8 and 12 weeks participants performed 1rM mus-
cular strength tests using an isotonic 45° leg press (nebula 
Fitness, Inc., Versailles, OH) and bench press (nebula Fit-
ness, Inc., Versailles, OH). Participants began the 1rM leg 
press and bench press test by first completing five to ten 
repetitions at approximately 50 % of their previously estab-
lished 1rM. Following a 2-min rest, three to five repeti-
tions were performed at approximately 70 % of their 1rM. 
From this time forward, the weight was increased gradu-
ally, until an official 1rM was reached. the rest period 
between each successful lift was 2 min. test–retest reli-
ability for performing these strength assessments on par-
ticipants within our laboratory has demonstrated low mean 
coefficients of variation and high reliability for the bench 
press (1.9 %, intraclass r = 0.94) and leg press (0.7 %, 
intraclass r = 0.91), respectively.
resistance training program
Participants completed a partially supervised resistance 
training program. Partially supervised means that each par-
ticipant was supervised for the first 2 weeks to ensure cor-
rect technique was being implemented. Participants were 
then monitored (i.e. correct technique used, correct weight 
lifted etc.) at the gym at 6, 8 and 11 weeks. Participants 
utilized either local fitness centers of which they were a 
member or facilities on the Baylor University campus. 
Participants participated in a partially supervised resist-
ance training program three times per week for the duration 
of the study. Participants completed resistance exercises 
similar to those utilized by chrusch et al. (2001). Partici-
pants completed the bench press, lat pull-down, biceps 
curl, triceps press down, leg press, leg extension and leg 
curl. three sets of 10 repetitions were completed for each 
exercise. An intensity of 75 % of 1rM was utilized dur-
ing training. Upon successful completion of 3 sets of 10 
repetitions, an increase of 5 % of weight was utilized to 
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ensure progressive overload during the study took place. A 
rest period of 1 min separated each set. Participants were 
asked to keep training logs detailing amount of weight uti-
lized, number of repetitions completed and number of sets 
completed.
nutritional supplementation
Participants were randomly assigned to receive, in a double-
blind manner, either 20 g of crM (Alschem, Degussa Inc., 
Atlanta, gA) combined with 5 g of glucose (Dgc ASt Sport 
Science, golden, cO) for 7 days followed by 0.1 g kg−1 
(average dosage of ~8.8 g) of crM with 5 g of glucose on 
training days or 20 g of glucose only for 7 days followed by 
5 g of glucose on training days. Each supplement dosage 
was provided in small identical plastic bags. Supplement was 
given to participants in a 4-week block period and thus dos-
age could be adjusted following body-weight analysis. Each 
supplement was similar in color and texture. A small shaker 
bottle was provided to participants with instructions on how 
to mix the supplement in about 500 ml of water. Participants 
receiving crM completed a 7-day loading period with 20 g 
of crM being ingested daily in 4 × 5 g increments (i.e. 9 am, 
12, 3 and 6 pm). Participants in both the experimental group 
(crM-cHO) and the placebo control group (cHO) began 
the designed supplementation protocol immediately after 
baseline testing which took place on Day 0. Following the 
7 day loading phase, participants were instructed to ingest 
either the supplement or placebo within 60 min following the 
resistance exercise session for the duration of the 12-week 
study period. Justification of the supplementation protocol is 
threefold: First, a lower dosage of 0.07–0.1 g kg−1 (approxi-
mately 5–8 g days−1) results in minor adverse events (i.e., 
loose stools, muscle cramping, and muscle pulls/strains) 
(chrusch et al. 2001; candow et al. 2008). Second, a dos-
age as little as 5 g days−1, albeit continuous, has shown to be 
effective at increasing lean muscle mass and strength in older 
males (Brose and Parise 2003; chrusch et al. 2001). And 
finally, a single 5 g oral dose of crM in healthy adults results 
in a peak plasma creatine level of approximately 120 mg/l at 
1–2 h post-ingestion (i.e., during that post-exercise window) 
(Jager et al. 2007). compliance monitoring was accom-
plished by having participants return empty containers of the 
supplement or placebo at each testing session. compliance to 
the supplementation protocol was monitored by supplement 
logs and verbal confirmation. compliance was also verified 
through the administration and collection of questionnaires 
from each participant regarding any noticeable side-effects.
tissue and blood sampling
Skeletal muscle biopsies were collected accordingly to pre-
viously published procedures (cooke et al. 2011). Briefly, 
percutaneous muscle biopsies were obtained using the 
Bergstroem technique under local anesthesia of 1 % Xylo-
caine from middle portion of the vastus lateralis muscle of 
the dominant limb at the midpoint between the patella and 
the greater trochanter of the femur at a depth between 2 and 
3 cm. Muscle samples were obtained by standard/sterile 
procedures by personnel who were experienced in perform-
ing the procedure. After removal, the tissue samples were 
immediately frozen in liquid nitrogen and then stored at 
−80 °c for future analyses.
Participants were required to fast overnight prior to 
donating approximately 20 ml of venous blood from the 
antecubital vein using standard phlebotomy procedures. 
Blood was collected into serum separation tubes and cen-
trifuged at 1,100g for 15 min. Serum was separated and 
stored at −80 °c in polypropylene tubes for later analysis.
Serum insulin-like growth factor 1 and testosterone
Serum samples were analyzed in duplicate for free/bioac-
tive IgF-1 (Diagnostic Systems laboratories, Webster, 
tX), and free testosterone (Alpha Diagnostic International, 
San Antonio, tX) using an ElISA (enzyme linked immu-
noabsorbent assay). For IgF-1, assay sensitivity is 0.06 ng/
ml, and does not cross-react with albumins or gH (growth 
hormone) binding proteins. For testosterone, sensitivity 
is 0.17 pg/ml. For IgF-1 and testosterone the subsequent 
absorbances, which were directly proportional to the con-
centration of analyte in the sample, were measured at a 
wavelength of 450 nm using a microplate reader (Wallac 
Victor 1420, Perkin Elmer, Boston MA). A set of stand-
ards of known concentrations for IgF-1 and testosterone 
were utilized to construct standard curves by plotting the 
net absorbance values of the standards against their respec-
tive protein concentrations. By applying a four-part param-
eter curve using MikroWin microplate data reduction soft-
ware (Microtek lab Systems, germany), the free IgF-1 
and free testosterone concentrations in the serum samples 
were calculated. the overall intra-assay percent coefficient 
of variation was 4.9 and 3.7 % for IgF-1 and testosterone, 
respectively.
Fiber type and cross-sectional area
Muscle tissue used for determination of muscle fiber type 
and cSA were taken at 0 and 12 weeks. tissue obtained 
from the biopsy procedure was mounted using Oct 
medium and snap frozen in isopentane, pre-cooled in liquid 
nitrogen, and stored at −80 °c for histochemical analysis 
to classify muscle fiber types into fast (II) and slow (I) on 
the basis of the stability of their AtPase activity, as previ-
ously described (cribb and Hayes 2006). Fiber type cSA 
was determined from sections containing a mean of 210 
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(range 130–400) fibers. Samples were measured on two 
separate occasions for day-to-day reproducibility. Icc 
(intraclass correlation coefficient) and SD (standard devia-
tion) for fiber type distribution were type I r = 0.81, SD 
1.6 % and type II r = 0.93, SD 1.4 %.
Myofibrillar protein content
total cellular rnA (ribonucleic acid) was extracted from 
biopsy samples with a monophasic solution of phenol and 
guanidine isothiocyanate contained within the trI-reagent 
(Sigma chemical co., St. louis, MO), and then isolated 
with 100 % isopropanol. the interphase was removed and 
total (soluble + insoluble) muscle protein was then iso-
lated from the organic phase with 100 % isopropanol and 
washed with a 0.3 M guanidine Hcl/95 % ethanol solution. 
Myofibrillar (soluble) protein was further isolated with 
repeated incubations in 0.1 % SDS at 50 °c and separated 
by centrifugation. total myofibrillar protein content was 
determined spectrophotometrically based on the Bradford 
method at a wavelength of 595 nm (Bradford 1976). A 
standard curve was generated (R = 0.98, p = 0.001) using 
bovine serum albumin (Bio-rad, Hercules, cA), and total 
myofibrillar protein content was expressed relative to mus-
cle wet-weight.
Dietary records
Participants were required to keep dietary records for 
7 days prior to the exercise testing sessions. the 7-day die-
tary records were evaluated with the ESHA Food Processor 
8.6 (ESHA research, Salem, Or) dietary assessment soft-
ware program to determine the average daily macronutri-
ent consumption of fat, carbohydrate and protein, and con-
sumption of antioxidant-related micronutrients vitamin A, 
vitamin c, vitamin E and selenium in the diet.
Statistical analysis
Data was analyzed by utilizing separate 2 × 4 [group 
(crM-cHO, cHO)] × test (week 0, week 4, week 8, week 
12) mixed design factorial multivariate analysis of vari-
ance (MAnOVA). MAnOVAs were analyzed for this study 
based on dependent variables that are likely to be related 
to one another. In addition, the use of a MAnOVA analy-
sis prevents the potential for the increasing of type I error 
rate that might result with the use of repeated univariate 
procedures. AnOVA on each dependent variable was con-
ducted as a follow-up test to any significant MAnOVA. 
to control for alpha inflation of the AnOVA, the Bonfer-
roni test was utilized as a follow-up test. Post-hoc tests of 
any interaction effects demonstrated in the AnOVA were 
investigated via an independent samples t test. In addition 
to reporting probability values, an index of effect size was 
reported to reflect the magnitude of the observed effect. 
the index of effect size utilized was the partial Eta squared 
(η2), which estimates the proportion of variance in the 
dependent variable that can be explained by the independ-
ent variable. Partial Eta squared effect sizes were deter-
mined to be: weak = 0.17, medium = 0.24, strong = 0.51, 
very strong ≥0.70 as previously described by O’connor, 
et al. All statistical procedures were performed using SPSS 
20.0 software (chicago, Il) and an alpha probability level 
of <0.05 was adopted throughout. In addition, for all sta-
tistical analyses not meeting the sphericity assumption for 
the within-participant analyses, a Huynh–Feldt correc-
tion factor was applied to the degrees of freedom to adjust 
(increase) the critical F value to a level that would prevent 
the likelihood of committing a type I error.
Results
Participants
At baseline, there were no significant differences between 
groups with regards to height (cm) (crM-cHO: 177.3 ± 7.4 
vs. cHO: 175.1 ± 5.0, p = 0.451), body weight (kg) (crM-
cHO: 88.2 ± 12.3 vs. cHO: 94.4 ± 15.3, p = 0.332), and 
age (years) (crM-cHO: 61.4 ± 5.0 vs. cHO: 60.7 ± 5.4, 
p = 0.762). A Shapiro–Wilk test was used to test for the 
normality of data and given non-significance was found; 
we were able to reject the alternative hypothesis and con-
clude that the data came from a normal distribution.
nutritional intake analysis
All participants were instructed to consume their usual 
diet during the 12-week course of the study. Dietary anal-
ysis does not include information related to the supple-
ment ingested. However, monitoring of supplement logs 
and verbal confirmation of supplement compliance (data 
not shown) indicated that supplementation compliance 
was 100 %. Independent sample t tests were utilized to 
analyze all relevant dietary variables prior to commence-
ment of supplementation and the resistance training pro-
gram. table 1 illustrates that at baseline (t1), there were 
no significant differences observed between groups for 
total daily caloric intake, macronutrient intake of protein, 
or carbohydrate. Following supplementation, a multivari-
ate analysis revealed a strong trend towards significance for 
time [Wilk’s lambda = 0.057, F(4,12) = 5.514, p = 0.056, 
effect size (η2) = 0.943, power = 0.632]. Univariate analy-
sis detected a significant time effect for dietary fat intake 
(p = 0.025, η2 = 0.189, power = 0.727), with subse-
quent post-hoc analysis revealing significant increases in 
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dietary fat intake from t2 to t4 (p = 0.009) and t3–t4 
(p = 0.013). In addition, dietary fat intake was significantly 
higher in the cHO group compared to the crM-cHO group 
at t4 (p = 0.04). these results indicate that while both 
groups increased their dietary fat intake from t2 to t4, the 
cHO group was ingesting significantly more dietary fat 
compared to the crM-cHO group at t4. no other signifi-
cant main effects for time, group, or group by time inter-
actions were detected for dietary protein and carbohydrate 
intake.
total lifting volume analysis
All participants were instructed to record, for each exer-
cise, the number of repetitions and weight lifted at each 
training session. total lifting volume for each group 
reflects the total number of repetitions multiplied by the 
total weight lifted performed by each participant for each 
exercise (4 weeks: crM-cHO: 118,780 ± 25,485 kg, 
cHO: 129,500 ± 33,137 kgs, p = 0.500; 8 weeks: 
crM-cHO: 130,060 ± 38,313 kgs, cHO: 
147,000 ± 40,384 kgs, p = 0.422; 12 weeks: crM-cHO: 
142,220 ± 55,236 kgs, cHO: 156,630 ± 41,715 kgs, 
p = 0.331). Independent sample t tests were utilized to 
analyze the total lifting volume at baseline, and repeated 
measures AnOVA was utilized to assess changes in total 
lifting volume over time. A statistical trend for time 
[F(2,12) = 3.414, p = 0.067, effect size(η2) = 0.363] 
was detected indicating both groups increased their 
training output following 12 weeks of resistance 
training.
Muscle strength analysis
Data for 1rM bench press and leg press are repre-
sented in Figs. 1 and 2. Mulitivariate analysis indi-
cated a significant time effect [Wilk’s lambda = 0.289, 
F(6,13) = 5.336, p = 0.006, η2 = 0.71, power = 0.941] 
with no significant group or group × time interactions. 
Univariate analysis revealed a significant time effect for 
1rM bench press [F(3,16) = 0.016, p = 0.016, effect 
size (η2) = 0.468], with subsequent pairwise analysis 
displaying significant increases from baseline (t1) to t3 
(p = 0.022), and t4 (p = 0.003), and t2–t3 (p = 0.022), 
and t4 (p = 0.002). Similarly, univariate analysis 
revealed a significant time effect for 1rM leg press 
[F(3,16) = 10.543, p = 0.012, effect size (η2) = 0.664], 
with subsequent pairwise analysis revealing a signifi-
cant increase from baseline (t1) to t2 (p < 0.05), t3 
(p < 0.01) and t4 (p < 0.05).
Body composition analysis
Data for body mass (kg), body fat (%), fat-free mass 
(kg) and fat mass (kg) are presented in table 2. Mul-
tivariate analysis revealed a significant effect for time 
(Wilks’s lambda = 0.046, F(4,15) = 12.108, p = 0.001, 
η2 = 0.954, power = 0.998) and a trend towards sig-
nificance for group effect (p = 0.078). no group × time 
interaction was found. Univariate analysis indicated a sig-
nificant time effect for body mass [F(3,16), p = 0.030, 
η2 = 0.419] with subsequent pairwise analysis revealing 
significant increases in body mass between baseline (t1) 
and t2 (p = 0.008), t3 (p = 0.005), and t4 (p = 0.003) 
indicating both crM-cHO, and cHO significantly 
increased body mass following 12 weeks of resistance 
training. A strong statistical trend for group was detected 
for body fat % (p = 0.0 58), indicating higher body fat 
% in the cHO group compared to the crM-cHO group 
throughout the study period. A significant time effect 
was detected for fat-free mass (p = 0.005, η2 = 0.212, 
power = 0.884) with subsequent pairwise analysis reveal-
ing significant increases between baseline (t1) and t2 
(p = 0.004), t3 (p = 0.004), and t4 (p = 0.018), indicat-
ing both crM-cHO, and cHO significantly increased fat-
free mass following 12 weeks of resistance training. Simi-
lar to body fat %, a trend towards significance for group 
was detected for fat mass (p = 0.075), indicating higher 
body fat % in the cHO group compared to the crM-cHO 
group during the study period.
Table 1  comparison of nutritional intake variables between crM-
cHO and cHO groups
Data are presented as mean ± standard deviation
†
  Significantly different from t2 (p < 0.05)
‡
  Significantly different from t3 (p < 0.05)
§
  Significantly different between groups (p < 0.05)
Variable time crM-cHO cHO Significance
Energy intake 
(kcal days−1)
t1 2,127 ± 423 1,889 ± 374 group = 0.883
t2 1,834 ± 681 2,006 ± 600 time = 0.142
t3 1,939 ± 454 1,834 ± 528 G × T = 0.167
t4 2,024 ± 490 2,432 ± 680
cHO intake 
(g days−1)
t1 232 ± 61 208 ± 60 group = 0.901
t2 223 ± 120 241 ± 119 time = 0.885
t3 237 ± 53 211 ± 97 G × T = 0.603
t4 228 ± 83 241 ± 139
Protein intake 
(g days−1)
t1 98 ± 34 83 ± 18 group = 0.829
t2 84 ± 28 78 ± 8 time = 0.161
t3 75 ± 15 73 ± 13 G × T = 0.449
t4 91 ± 19 108 ± 74
Fat intake 
(g days−1)
t1 95 ± 36 81 ± 24 group = 0.773
t2 68 ± 25 84 ± 29 time = 0.056
t3 76 ± 31 80 ± 25 G × T = 0.207
t4 83 ± 28 116 ± 32†,‡,§
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Fig. 1  time course of 1rM 
bench press. Data (mean ± SD) 
represents 1rM bench press 
for both crM-cHO and cHO 
groups, including the mean 
average for both groups com-
bined, following 12 weeks of 
resistance training. Asterisk sig-
nificantly different from base-
line (t1) (p < 0.05). Dagger 
symbol significantly different 
from t2 (p < 0.05). Please note 
that symbols used are a reflec-
tion of pairwise analysis for 
time effects and thus differences 
between mean averages for both 
groups combined (mean average 
line in figure) at each time point W
ei
gh
t (
kg
)
Testing Session
Fig. 2  time course of 1rM leg 
press. Data (mean ± SD) rep-
resents 1rM leg press for both 
crM-cHO and cHO groups, 
including the mean average 
for both groups combined, fol-
lowing 12 weeks of resistance 
training. Asterisk significantly 
different from baseline (t1) 
(p < 0.05). Please note that 
symbols used are a reflection 
of pairwise analysis for time 
effects and thus differences 
between mean averages for both 
groups combined (mean average 
line in figure) at each time point
W
ei
gh
t (
kg
)
Testing Session
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Serum analysis
Data for serum IgF-1 and free testosterone are repre-
sented in table 3. Multivariate analysis indicated a trend 
for time [Wilk’s lambda = 0.276, F(9,10), p = 0.056, 
η2 = 0.724, power = 0.703]. no significant time, group or 
group × time interaction was observed.
Skeletal muscle analysis
Data for total myofibrillar protein concentration and mus-
cle fiber cSA are presented in table 4. A repeated meas-
ures AnOVA revealed a significant time effect for total 
myofibrillar protein content [F(3,15) = 3.509, p = 0.042, 
effect size (η2) = 0.412] with no significant group or 
group × time interactions. Subsequent pairwise analysis 
showed a significantly higher total myofibrillar protein 
concentration at t4 compared to baseline (p = 0.005). 
Student’s t test revealed a trend (p = 0.08) for an increase 
in size of type II muscle fiber cSA following 12-week 
resistance training. no significant differences were 
observed between type I and II cSA or following creatine 
supplementation.
Discussion
the primary purpose of this study was to determine if the 
consumption of creatine in the hour window post-exer-
cise would stimulate greater training-induced increases 
in lean muscle mass, muscle fiber cSA and myofibrillar 
protein content concomitant with upper and lower body 
muscle strength gains compared to cHO placebo inges-
tion. In the current study, 12 weeks of resistance training 
increased body mass, fat-free mass and both upper body 
and lower body strength. In addition, significantly higher 
levels of myofibrillar protein concentration and larger mus-
cle fiber cSA, albeit not significant, were observed follow-
ing the 12-week resistance training program. Despite these 
improvements, ingesting creatine post-exercise did not 
enhance the observed resistance training-induced changes 
in body composition and/or muscle strength.
Table 2  Body composition for crM-cHO and cHO groups
Data are presented as mean ± standard deviation
* Significantly different from baseline (t1) (p < 0.05)
Variable t1 t2 t3 t4 Significance
Body mass (Kg) group = 0.093
 crM-cHO 88.2 ± 12.4 89.3 ± 11.9* 89.8 ± 12* 89.9 ± 11.8* time = 0.030
 cHO 94.4 ± 15.3 94.9 ± 15.1* 94.8 ± 15.3* 95.1 ± 15.5* G × T = 0.638
Body fat (%) group = 0.058
 crM-cHO 26.7 ± 3.5 26.1 ± 3.4 25.6 ± 2.6 26.5 ± 3.8 time = 0.232
 cHO 29.8 ± 4.3 29.3 ± 3.8 29.6 ± 4.2 29.8 ± 4.9 G × T = 0.538
Fat mass (Kg) group = 0.075
 crM-cHO 21.6 ± 4.8 21.5 ± 4.6 21.3 ± 5.0 21.0 ± 4.3 time = 0.103
 cHO 25.8 ± 5.3 25.6 ± 5.0 26.0 ± 5.9 26.2 ± 6.4 G × T = 0.289
Fat-free mass (Kg) group = 0.516
 crM-cHO 56.6 ± 7.1 58.3 ± 7.2* 59.1 ± 7.4* 58.6 ± 7.9* time = 0.005
 cHO 58.9 ± 11.2 60.1 ± 11.1* 59.6 ± 10.6* 59.4 ± 10.7* G × T = 0.769
Table 3  Serum variables for crM-cHO and cHO groups
Data are presented as mean ± standard deviation
Variable t1 t2 t3 t4 Significance
IgF-1 (pg/ml) group = 0.093
 crM-cHO 510 ± 300 424 ± 322 532 ± 310 505 ± 304 time = 0.261
 cHO 280 ± 300 280 ± 230 345 ± 245 283 ± 312 G × T = 0.638
testosterone (pg/ml) group = 0.516
 crM-cHO 114 ± 94 116 ± 84 109 ± 71 123 ± 89 time = 0.531
 cHO 159 ± 110 158 ± 146 126 ± 69 148 ± 126 G × T = 0.769
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In young and older populations, greater gains in body 
and lean muscle mass and muscular strength have been 
observed following a standard creatine supplementation 
protocol in conjunction with a resistance training program 
compared to supplementation or resistance training alone 
(Becque and lochman 2000; Bermon et al. 1998; chrusch 
et al. 2001; Kreider 2003; Willoughby and rosene 2001). 
Participants typically consume 0.3 g kg−1 or approximately 
20–25 g days−1 of crM for 5–7 days (“loading phase”) 
and 0.07 g kg−1 or approximately 2–5 g days−1 of crM 
thereafter (“maintenance phase”). Although this protocol 
has been shown to be effective, others have excluded the 
loading phase and only used a continuous low dosage (i.e., 
5–7.7 g days−1) and were able to increase lean muscle mass 
and muscular performance over placebo-supplemented 
groups (Brose and Parise 2003; Burke et al. 2000).
In the current study following a standard “loading” pro-
tocol, crM ingestion of ~8.8 g post-exercise was unable 
to enhance body composition (i.e. gains in fat-free mass, 
loss of body fat), muscle strength, total myofibrillar pro-
tein content and/or individual muscle fiber cSA following 
a 12-week resistance training program. these observa-
tions are in agreement with others who have used a lower 
dosage (3–5.7 g) before and/or after exercise and failed to 
show any benefit on exercise-induced adaptations to exer-
cise (candow et al. 2008; Eijnde et al. 2003). Eijnde et al. 
(2003) instructed their participants to ingest 3 g of creatine 
(of the 5 g days−1) post-exercise for a period of 24 weeks; 
where as candow et al. (2008) ingested approximately 
2.85 g of creatine (of the approximate 8 g days−1) before 
and after exercise for a period of 10 weeks. Interestingly, 
when protein (~24 g days−1) was combined with the low 
creatine dosage, greater gains were seen in lean muscle 
mass and strength compared to placebo group (candow 
et al. 2008). However, given the well established effects 
of protein/amino acid supplementation on muscle protein 
stimulation, the observed results are most likely due to pro-
tein supplementation and not the creatine per se.
contrary to our findings, chilibeck et al. (2004) dem-
onstrated greater increases in elbow flexor muscle thick-
ness and lean mass tissue (males only) when creatine was 
ingested after a single limb training session twice a week 
for 6 weeks. It is not readily apparent as to why our hypoth-
esis was not supported. It is clear that the dosage used by 
chilibeck et al. (2004) was higher and the duration was 
shorter compared to the current study (~15.5 vs. ~8.8 g, 6 
vs. 12 weeks) and thus could explain why the current study 
didn’t show any significant benefit from the post-exercise 
creatine supplementation. However, when you average the 
dosage intake over the entire week, the difference seems 
to be minor (~4.5 vs. ~3.8 g days−1). We decided to use a 
lower dosage and longer supplement duration because oth-
ers (chrusch et al. 2001; Brose and Parise 2003) have dem-
onstrated that following a typical “loading” protocol and/
or continuous low dosage (5 g days−1) supplementation 
period combined with resistance exercise, enhancement of 
body composition and improvements in muscular perfor-
mance are typically observed. Although not measured in 
the study by chrusch et al. (2001), the level of intramus-
cular creatine has been shown to influence the performance 
(Snow and McKenna 1998; casey and constantin-teodo-
siu 1996); with a positive effect following crM supplemen-
tation normally associated with large increases in intramus-
cular creatine following supplementation. thus, we wanted 
to determine if post-exercise consumption (at a low dosage) 
following a typical “loading” protocol would be effective.
therefore, the question is: Does a certain level of intra-
muscular creatine need to be achieved (i.e., via a typical 
“loading” protocol and/or continuous ingestion) to stimu-
late muscle growth or can acute muscle uptake of creatine 
(i.e., following pre- and/or post-exercise ingestion) have 
a similar effect? A limitation in our study and chilibeck 
et al. (2004) is that total intramuscular crM concentrations 
were not measured. Unlike chilibeck et al. (2004), we per-
formed a standard loading protocol at the beginning and 
can only speculate that total intramuscular creatine levels 
Table 4  Muscle variables for crM-cHO and cHO groups
Data are presented as mean ± standard deviation
* Significantly different from baseline (t1) (p < 0.05)
Variable t1 t2 t3 t4 Significance
Fiber cSA (μm2 10−3)
 crM-cHO type I 3.1 ± 0.6 4.8 ± 1.1
 cHO type I 3.8 ± 1.5 4.7 ± 0.9
 crM-cHO type II 2.9 ± 1.1 4.0 ± 0.6
 cHO type II 3.2 ± 0.6 4.0 ± 0.9
total myofibrillar protein content (μg/mg muscle) group = 0.316
 crM-cHO 7.9 ± 4.0 10.5 ± 8.7 10.1 ± 1.9 12.0 ± 3.4* time = 0.042
 cHO 8.5 ± 2.2 8.1 ± 2.6 11.7 ± 7.7 11.1 ± 4.4 G × T = 0.669
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were increased and maintained throughout the study. How-
ever, even if intramuscular levels were increased, we were 
unable to demonstrate any significant effects from the post-
exercise creatine ingestion. therefore, when supplement-
ing acutely (i.e. pre- and/or post-exercise) dosage amount 
(i.e. a higher dosage) could be an important determinant 
of creatine’s effects within the muscle. Unlike protein sup-
plementation where a series of very well designed studies 
by Stuart Phillip’s lab (Breen and Phillips 2012) and others 
(van loon and gibala 2011) have determined the threshold 
for protein dosage and maximal protein synthesis; to date, 
no similar studies have been performed for creatine supple-
mentation. It could be suggested that a certain amount or 
“threshold” of creatine is needed to regulate muscle growth 
when taken acutely. Future work into the timing of creatine 
supplementation should examine different dosage amounts 
and its ability to acutely regulate hypertrophic signalling.
It should be noted that the cHO group was ~6 kg heav-
ier compared to the crM-cHO group at baseline. Although 
this body mass difference was not deemed significant, it 
could be argued that this difference may have played a role 
in adaptive responses to the resistance exercise program. 
However, total lifting volume data indicated that both 
groups increased their workload by similar amounts (crM-
cHO ~20 % and cHO ~21 %) and taken together with the 
lean mass changes; we can argue that the body mass differ-
ence at baseline did not significantly influence the results 
of the study. Another interesting observation was higher fat 
intakes in the cHO group when compared with the crM-
cHO group. It is not readily apparent as to why the cHO 
group consumed higher amounts of fat. regardless, there is 
little evidence to suggest that higher fat intakes would have 
a significant effect on the adaptations to resistance training. 
More importantly, no significant differences were shown in 
total protein intake and total calories, both known to influ-
ence muscle growth and adaptations to exercise.
to our knowledge, the current study is the first to exam-
ine long-term effects of crM ingestion on serum anabolic 
hormones, IgF-1 and testosterone responses to resistance 
exercise in middle to older men. It is evident from previ-
ous literature that both hormones are important to maximize 
functional adaptations to resistance training (Schroeder et al. 
2013). In fact, exogenous administration of testosterone to 
hypogonadal males has resulted in significant increases in 
muscle mass and decreases in fat mass as well as increases in 
muscle strength (Bhasin and Woodhouse 2001). In the cur-
rent study, baseline serum testosterone and IgF-1 levels were 
close or within the normal ranges for men: 29.9–269.2 pg/
ml, testosterone and 180–810 pg/ml, IgF-1 (Vermeulen 
1996). Following the 12-week training and supplementa-
tion protocol, no significant changes in IgF-1 or testoster-
one levels were observed over the course of the study. How-
ever, there was a trend towards significance for higher serum 
IgF-1 between 4 and 8 weeks for both groups (p = 0.066). 
the results of this study are in agreement with previous find-
ings using resistance training only in older men (nicklas and 
ryan 1995; Brose and Parise 2003). nicklas and colleagues 
(nicklas and ryan 1995) demonstrated that 16 weeks of 
progressive resistance training in males older than 55 years 
of age had no significant influence on baseline serum IgF-
1, testosterone and growth hormone concentrations. though 
serum growth hormone was increased following an acute 
bout of resistance exercise, serum concentrations of testos-
terone and IgF-1 were not affected by the resistance training 
program. likewise, Izquierdo and colleagues (Izquierdo and 
Hakkinen 2001) showed no significant changes in serum-
free testosterone following a 16-week resistance training 
program in middle and older aged males. Interestingly, simi-
lar to the current study, upper and lower body strength was 
increased over time. It could be suggested that since blood 
samples were obtained 48 h following the last bout of exer-
cise, it is likely that serum IgF-1 and testosterone concen-
trations returned to baseline levels. Indeed, previous studies 
examining the short-term response to serum IgF-1 and tes-
tosterone concentrations following an acute bout of resist-
ance exercise have demonstrated an increase shortly within 
the recovery period (12–48 h) (Florini and Ewton 1996), 
with levels normally returning to baseline within 48 h. Fur-
thermore, creatine supplementation and/or resistance exer-
cise are potentially increasing intramuscular IgF-1 and thus 
enhancing the anabolic status of the cell (Singh et al. 1999; 
Burke et al. 2008). With this in mind, given the significant 
increases in lean muscle mass, total myofribillar protein 
content and upper and lower body strength in the current 
study; it could be speculated that transient increases in serum 
and muscle IgF-1 and/or testosterone shortly following the 
resistance exercise session are eliciting their anabolic effects 
within the muscle.
In summary, the results of the present study indicate that 
post-exercise supplementation with crM combined with a 
12-week high intensity resistance training program does 
not provide greater enhancement of body composition or 
muscle strength compared to cHO ingestion alone in mid-
dle to older males. However, it is clear that high intensity 
resistance training can significantly enhance body compo-
sition and muscular strength as evident by changes at the 
whole muscle and cellular level, and thus be an effective 
method at combating muscle wasting (sarcopenia) and 
frailty, commonly seen in the elderly. Future studies should 
examine the acute and chronic effects of different dosages 
of creatine ingestion before and/or after resistance exercise 
on pathways involved in skeletal muscle growth.
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